Akari Therapeutics PLC (AKTX) stock news · $17.2M cap
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
This AKTX news page leads with what Akari Therapeutics PLC filed — not a scraped headline mill.
No cached 8-K sentence for AKTX yet. We will not pad this page with generic market recap.
Latest reported AKTX revenue for 2024-06-30 was $0. Net income was -$7.6M. AKTX currently screens at market cap $17.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AKTX stock page; for the tape open the quote page.
AKTX stock news FAQ
What is AKTX's latest net income?
Latest cached Akari Therapeutics PLC (AKTX) net income was -$7.6M. Statements: https://lician.com/financials/aktx
What is AKTX's market cap?
Akari Therapeutics PLC (AKTX) market cap is $17.2M on the latest cached fundamentals snapshot.
What kind of company is AKTX?
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Where is AKTX stock news listed?
Cached stock news for Akari Therapeutics PLC (AKTX) is listed at https://lician.com/news/aktx. Filings: https://lician.com/sec/aktx
Not investment advice.